Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Organic heterocyclic compounds that consist of a six-membered ring containing five carbon atoms and one nitrogen atom that forms an amine functional group.
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Quisinostat dihydrochloride (CAS 875320-31-3) also known as JNJ-26481585 dihydrochloride is an orally bioavailable pan-histone deacetylase (HDAC) inhibitor It potently suppresses the enzymatic activity of several HDAC isoforms including HDAC1 (IC50 0 11 nM) HDAC2 (IC50 0 33 nM) HDAC4 (IC50 0 64 nM) HDAC10 (IC50 0 46 nM) and HDAC11 (IC50 0 37 nM) By interfering with histone deacetylation Quisinostat dihydrochloride induces apoptosis and cell cycle arrest in tumor cells This compound is widely utilized in studies addressing tumor biology and epigenetic regulation
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Quisinostat dihydrochloride (CAS 875320-31-3) also known as JNJ-26481585 dihydrochloride is an orally bioavailable pan-histone deacetylase (HDAC) inhibitor It potently suppresses the enzymatic activity of several HDAC isoforms including HDAC1 (IC50 0 11 nM) HDAC2 (IC50 0 33 nM) HDAC4 (IC50 0 64 nM) HDAC10 (IC50 0 46 nM) and HDAC11 (IC50 0 37 nM) By interfering with histone deacetylation Quisinostat dihydrochloride induces apoptosis and cell cycle arrest in tumor cells This compound is widely utilized in studies addressing tumor biology and epigenetic regulation
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
PI-1840 (CAS 1401223-22-0) is a potent selective and rapidly reversible noncovalent inhibitor of the proteasome chymotrypsin-like (CT-L) activity It exhibits an IC50 of 27 nM against CT-L catalytic function of the proteasome with significantly greater selectivity over other proteolytic activities including PGPH-L and T-L In MDA-MB-468 human breast cancer cells PI-1840 inhibits CT-L activity (IC50 0 37 M) suppresses cell viability and proliferation and induces accumulation of CT-L substrates such as I B- p27 and Bax ultimately triggering apoptosis via PARP cleavage and caspase-3 activation In vivo PI-1840 markedly reduces tumor growth in a breast cancer xenograft model This compound is valuable for investigating proteasome function apoptosis and cancer biology
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More